Adamantane-based inhibitors of the influenza A M2 proton channel: structure-based design, biological evaluation, and synthetic approaches

Marianna Stampolaki, Maria-Eleni Kouridaki, Kyriakos Georgiou, Antonios Kolocouris

Open source

DOI
10.1039/d5md01027f
Published
2026
Container
RSC Medicinal Chemistry
Publisher
Royal Society of Chemistry (RSC)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1039/d5md01027f,
  title = {Adamantane-based inhibitors of the influenza A M2 proton channel: structure-based design, biological evaluation, and synthetic approaches},
  author = {Marianna Stampolaki and Maria-Eleni Kouridaki and Kyriakos Georgiou and Antonios Kolocouris},
  year = {2026},
  journal = {RSC Medicinal Chemistry},
  doi = {10.1039/d5md01027f},
  url = {https://doi.org/10.1039/d5md01027f}
}

RIS

TY  - JOUR
TI  - Adamantane-based inhibitors of the influenza A M2 proton channel: structure-based design, biological evaluation, and synthetic approaches
AU  - Marianna Stampolaki
AU  - Maria-Eleni Kouridaki
AU  - Kyriakos Georgiou
AU  - Antonios Kolocouris
PY  - 2026
JO  - RSC Medicinal Chemistry
DO  - 10.1039/d5md01027f
UR  - https://doi.org/10.1039/d5md01027f
ER  - 

APA

Stampolaki, M., Kouridaki, M., Georgiou, K., & Kolocouris, A. (2026). Adamantane-based inhibitors of the influenza A M2 proton channel: structure-based design, biological evaluation, and synthetic approaches. RSC Medicinal Chemistry. https://doi.org/10.1039/d5md01027f

Source records